UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

Frontiers in oncology, 2021-02, Vol.10, p.600573-600573

2021

Volltextzugriff (PDF)

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?

Cancers, 2019-07, Vol.11 (7), p.984

2019

Volltextzugriff (PDF)

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors

Frontiers in oncology, 2020-11, Vol.10, p.598626-598626

2020

Volltextzugriff (PDF)

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy

Molecular oncology, 2022-02, Vol.16 (4), p.885-903

2022

Volltextzugriff (PDF)

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer

Frontiers in immunology, 2019-08, Vol.10, p.1940-1940

2019

Volltextzugriff (PDF)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

Frontiers in immunology, 2018-05, Vol.9, p.947-947

2018

Volltextzugriff (PDF)

Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer

PloS one, 2024-05, Vol.19 (5), p.e0298362

2024

Volltextzugriff (PDF)

Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells

PloS one, 2024-04, Vol.19 (4), p.e0302130-e0302130

2024

Volltextzugriff (PDF)

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

Nature communications, 2022-02, Vol.13 (1), p.946-946, Article 946

2022

Volltextzugriff (PDF)

The potential of piR-823 as a diagnostic biomarker in oncology: A systematic review

PloS one, 2023-12, Vol.18 (12), p.e0294685-e0294685

2023

Volltextzugriff (PDF)

Exosome-delivered circRPS5 inhibits the progression of melanoma via regulating the miR-151a/NPTX1 axis

PloS one, 2023-06, Vol.18 (6), p.e0287347-e0287347

2023

Volltextzugriff (PDF)

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications

International journal of molecular sciences, 2017-10, Vol.18 (10), p.2229

2017

Volltextzugriff (PDF)

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies

Frontiers in oncology, 2023-05, Vol.13, p.1215332-1215332

2023

Volltextzugriff (PDF)

Matrix metalloproteinases: protective roles in cancer

Journal of cellular and molecular medicine, 2011-06, Vol.15 (6), p.1254-1265

2011

Volltextzugriff (PDF)

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Frontiers in oncology, 2022-11, Vol.12, p.1075329-1075329

2022

Volltextzugriff (PDF)

Editorial: Cancer genomics in the era of precision medicine

Frontiers in genetics, 2024, Vol.15, p.1378917-1378917

2024

Volltextzugriff (PDF)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

Journal of translational medicine, 2019-01, Vol.17 (1), p.9-9, Article 9

2019

Volltextzugriff (PDF)

Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis

Frontiers in oncology, 2021-06, Vol.11, p.681377

2021

Volltextzugriff (PDF)

The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival

Cancers, 2024-07, Vol.16 (13), p.2451

2024

Volltextzugriff (PDF)

Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks

Cell death & disease, 2023-07, Vol.14 (7), p.415-415, Article 415

2023

Volltextzugriff (PDF)

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

Journal of translational medicine, 2022-09, Vol.20 (1), p.1-442, Article 442

2022

Volltextzugriff (PDF)

Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2247

2024

Volltextzugriff (PDF)

Uncovering a neurological protein signature for severe COVID-19

Neurobiology of disease, 2023-06, Vol.182, p.106147-106147, Article 106147

2023

Volltextzugriff (PDF)

TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2

PloS one, 2013-02, Vol.8 (2), p.e57474-e57474

2013

Volltextzugriff (PDF)

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

International journal of molecular sciences, 2023-05, Vol.24 (9), p.8117

2023

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(63)

Sprache

Englisch
(63)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immune Checkpoint Inhibitors in Triple Negative Breast Cancer Treatment: Promising Future Prospects

Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?

Lactate Metabolism and Immune Modulation in Breast Cancer: A Focused Review on Triple Negative Breast Tumors

Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy

The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives

Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer

Activated NAD+ biosynthesis pathway induces olaparib resistance in BRCA1 knockout pancreatic cancer cells

Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications

The potential of piR-823 as a diagnostic biomarker in oncology: A systematic review

Exosome-delivered circRPS5 inhibits the progression of melanoma via regulating the miR-151a/NPTX1 axis

Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies

Matrix metalloproteinases: protective roles in cancer

Editorial: Cancer testis antigens in cancer: Recent developments as cancer biomarkers and therapeutic targets

Editorial: Cancer genomics in the era of precision medicine

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer

Transcription Factors: The Fulcrum Between Cell Development and Carcinogenesis

The LDHC-STAT3 Signaling Network Is a Key Regulator of Basal-like Breast Cancer Cell Survival

Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting

Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study

Uncovering a neurological protein signature for severe COVID-19

TGF-β-elicited induction of tissue inhibitor of metalloproteinases (TIMP)-3 expression in fibroblasts involves complex interplay between Smad3, p38α, and ERK1/2

Blood-Based Proteomic Profiling Identifies Potential Biomarker Candidates and Pathogenic Pathways in Dementia

Suchergebnisse filtern